Puluo pharmaceutical: net profit in the first quarter decreased by 29.96% year-on-year
Puluo pharmaceutical announced that it achieved a net profit of 152 million yuan in the first quarter of 2022, a year-on-year decrease of 29.96%.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's Road to Tackle Autoimmune Diseases Globally
The market of autoimmune diseases medication is vast both in China and overseas and presents great opportunities. However, the number of Chinese players specializing in autoimmune diseases is limited. This article introduced the autoimmune diseases medication market in China and explained why Chinese players are limited then give some recommendations on what efforts Chinese companies can make to compete with western players.
Yesterday 08:00 AM
Sep 30, 2022 05:31 PM
Aug 29, 2022 05:45 PM
Aug 26, 2022 05:38 PM
Aug 09, 2022 04:42 PM
Briefing Jun 10, 2022 10:53 AM
· Technology
Nonferrous metal plate strengthened due to shock, and changal shares rose by the limit
Briefing Jun 09, 2022 11:13 AM
· Industrials
General Administration of Customs: in the first five months of this year, China's total import and export value increased by 8.3% year on year
Briefing Jun 08, 2022 11:03 PM
· Financials
National Medical Insurance Bureau: in 2021, the accumulated burden of patients will be reduced by 1494.49 billion yuan
Briefing Jun 01, 2022 03:58 AM
· Consumer Staples
JD home appliances: 618 pre-sale payment of the balance opened for 10 minutes, and the turnover was 3 times higher than that of last year
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Staples
15 Chinese Companies to Watch in September 2022 – New Consumption
Oct 03, 2022 06:17 PM
Insight
In-depth
Insight
In-depth